A new UAB study will investigate the role of autoantibodies and the benefit of therapeutic plasma exchange on a deadly lung disease.
UAB Hospital continues to be highly ranked by U.S. News and World Report, and is noted as the No. 1 hospital in Alabama.
A UAB physician will co-chair a steering committee of global cystic fibrosis experts and clinical trial investigators to support the design, conduct and execution of the triple combination pivotal study program.
Physicians at UAB share tips on men’s health and how it affects heart health, sexual function and memory and decreases cancer risk.
Eleven outstanding faculty members were named recipients of the 2017 Dean’s Excellence Awards, an honor recognizing exceptional contributions made by School of Medicine faculty in service, teaching, research, diversity enhancement and mentorship.
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
As lung diseases worsen worldwide, UAB has launched a pre-doctoral training program in pulmonary research that will focus on lung diseases such as asthma, cancer, COPD, cystic fibrosis, pneumonia, lung injury and idiopathic pulmonary fibrosis.
Twelve School of Medicine faculty were recently honored as winners of the UAB Graduate Dean's Excellence in Mentorship Award.
UAB’s Jack Hasson has been named the 2017 Outstanding Clinician by the American Thoracic Society.
Page 1 of 6